Surgical and Survival Outcomes with Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Longitudinal Study in a Tertiary Cancer Center-Reference-Cited by-同舟云学术

Surgical and Survival Outcomes with Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer: A Longitudinal Study in a Tertiary Cancer Center

Published:2020 Issue:1 Volume:12 Page:27-30
ISSN:0974-8938
Container-title:Journal of South Asian Federation of Obstetrics and Gynaecology
language:en
Short-container-title:

Author:

Raghavendrachar Rekha B,Bhat Rani A,Dhakaria Vibhawari

Publisher

Jaypee Brothers Medical Publishing

Subject

Obstetrics and Gynecology

Link

https://www.jsafog.com/doi/pdf/10.5005/jp-journals-10006-1751

Reference13 articles.

1. 1. Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018;68(6):394–424. DOI: 10.3322/caac.21492.

2. 2. National Cancer Registry Program. Incidence, Distribution, Trends in Incidence Rates and Projections of Burden of Cancer. March 2016. pp. 43–62.

3. 3. du Bois A, Reuss A, Pujade-Lauraine E, et al. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: A combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials. Cancer 2009;115(6):1234–1244. DOI: 10.1002/cncr.24149.

4. 4. Kehoe S, Hook J, Nankivell M, et al. Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. Lancet 2015;386(9990):249–257. DOI: 10.1016/S0140-6736(14)62223-6.

5. 5. Strong VE, Selby LV, Sovel M, et al. Development and assessment of memorial sloan kettering cancer center's surgical secondary events grading system. Ann Surg Oncol 2015;22(4):1061–1067. DOI: 10.1245/s10434-014-4141-4.